Orthofix (NSDQ:OFIX) today announced it appointed Kimberley Elting to president of the global orthopedics business, effective immediately.
Elting, who most recently was the company’s chief legal and development officer, will succeed Paul Gonsalves who is pursuing other opportunities.
“With more than 25 years in the medical device space, a track record of success at Orthofix, and a demonstrated passion for our Orthopedics business, Kim will bring strong leadership and meaningful perspective to this business,” CEO Jon Serbousek said in a news release. “We have made significant investments to build the Orthopedics Business unit and we feel confident that she is the right person to lead this team to continue to drive growth in this sector of our business.”
Prior to the leadership transition, Elting held numerous leadership roles in Orthofix, including regulatory and quality, corporate communications, business development and legal. She will transition legal, business development and corporate communications responsibilities to new leaders.
“The orthopedics business was the foundation for Orthofix over forty years ago when this company was started in Verona, Italy, and it has a long history of providing meaningful products and life-changing patient solutions to orthopedic surgeons worldwide,” said Elting. “I look forward to working with this talented team as we continue to innovate and bring to market differentiated products and solutions for pediatric and adult deformity correction and limb reconstruction, helping deliver on our commitment to improve patient mobility.”
Elting previously was the general counsel and VP of corporate affairs at TriVascular Technologies and has held leadership roles at St. Jude Medical.